PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-7.08%
Negative net income growth while AVGO stands at 200.00%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
0.45%
Some D&A expansion while AVGO is negative at -9.60%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
185.58%
Some yoy growth while AVGO is negative at -64.29%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-1.89%
Both cut yoy SBC, with AVGO at -9.26%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
-160.15%
Both reduce yoy usage, with AVGO at -182.35%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
33.41%
AR growth is negative or stable vs. AVGO's 135.56%, indicating tighter credit discipline. David Dodd would confirm it doesn't hamper sales volume.
24.55%
Inventory shrinking or stable vs. AVGO's 650.00%, indicating lean supply management. David Dodd would confirm no demand shortfall.
-182.69%
Both negative yoy AP, with AVGO at -250.00%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-182.35%
Both reduce yoy usage, with AVGO at -296.39%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-253.77%
Negative yoy while AVGO is 48.39%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-62.31%
Negative yoy CFO while AVGO is 26.25%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
56.21%
CapEx growth well above AVGO's 14.29%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-100.00%
Negative yoy acquisition while AVGO stands at 305.05%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
39.14%
Purchases growth of 39.14% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
15.19%
We have some liquidation growth while AVGO is negative at -100.00%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
934.48%
We have some outflow growth while AVGO is negative at -94.22%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
69.96%
Lower net investing outflow yoy vs. AVGO's 1568.57%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
-222.27%
We cut debt repayment yoy while AVGO is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
-1240.34%
We cut yoy buybacks while AVGO is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.